Skip to content

Study · Measured the body's own peptide · 1998

2 results

Ontogeny of the vasopressin and oxytocin RNAs in the mouse hypothalamus.

Jing X, Ratty AK, Murphy D

Neuroscience research1 Apr 1998Cited by 34 (Europe PMC)

PMID9678638 (opens in a new tab)DOI10.1016/s0168-0102(98)00017-0 (opens in a new tab)PepBankPUB-09678638
Publisher pagePubMedAsk about this study
Jump to 2 results

Summary

The text of this summary is not shown here, because the article license does not allow reuse. Read it at the source (opens in a new tab)

Text rights: Publisher copyright. Results still quote short attributed sentences.

Results from this study2

No result from this study comes from a test of the peptide.

Natural levels measured2

These results measure the body's own peptide. Nobody was given the peptide. They are not evidence about taking it. They are left out of key results, evidence counts and charts.

  1. 01AnimalEndogenous levelAnimal study (in vivo)Other

    In the developing mouse hypothalamus, oxytocin RNA was first seen in the paraventricular nucleus at day 15.5, and in the supraoptic nucleus clearly at day 18.5.

    In plain wordsIn mice, the body's own oxytocin gene activity started in one brain area at day 15.5 and in another by day 18.5.

    Peptide
    Oxytocin
    Outcome
    Not applicableOnset of oxytocin RNA expression in hypothalamic nuclei
    Study

    mousen: not reported in source

    Outcome group
    Endogenous peptide levels · Endocrine and hormones

    Measurements

    Day of first oxytocin RNA, paraventricular nucleus
    15.5 embryonic day
    mouse hypothalamus
    Day of clear oxytocin RNA, supraoptic nucleus
    18.5 embryonic day
    mouse hypothalamus

    Source sentences

    Summary
    Oxytocin is seen first in the paraventricular at day 15.5; expression in the supraoptic nucleus is clearly seen at day 18.5.
    1 context sentence
    Summary · context
    As a first step in this process, we have used in situ hybridisation to study the expression of the RNAs encoded by the linked vasopressin and oxytocin genes during the development of the mouse hypothalamus.

    This result measures the body's own Oxytocin. Nobody was given the peptide. It is not evidence about taking it.

  2. 02AnimalEndogenous levelAnimal study (in vivo)Other

    In the mouse hypothalamus from day 15.5, oxytocin RNA and vasopressin RNA were expressed in different groups of neurons.

    In plain wordsIn mice, the body's own oxytocin and vasopressin genes were active in different groups of brain cells from day 15.5.

    Peptide
    Oxytocin
    Outcome
    Not applicableOxytocin and vasopressin RNA in different neuron groups
    Study

    mousen: not reported in source

    Outcome group
    Endogenous peptide levels · Endocrine and hormones

    Source sentences

    Summary
    As early as day 15.5, the vasopressin and oxytocin RNAs are expressed in different groups of neurons.
    1 context sentence
    Summary · context
    As a first step in this process, we have used in situ hybridisation to study the expression of the RNAs encoded by the linked vasopressin and oxytocin genes during the development of the mouse hypothalamus.

    This result measures the body's own Oxytocin. Nobody was given the peptide. It is not evidence about taking it.

AI wrote and checked these results. AI can make mistakes, so check important results against the source.

Version history

PepBank keeps every version of the data on this study. Status changes from Retraction Watch, Europe PMC and Crossref are listed with their source.

  1. Version 2Current

    11 Oct 2026, 20:03 UTC

    Study results updated

  2. Version 1

    9 Oct 2026, 02:51 UTC

    First added · source update from Europe PMC

Subjects

Terms as the source lists them.

PepBank is a research reference. Talk to a doctor before you use any peptide.